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Abstract
Purpose Obstructive sleep apnea (OSA) presents perioperative challenges with increased risk for complications. Floppy
eyelid syndrome (FES) is associated with OSA yet has not been addressed perioperatively. The current standard for perioperative OSA screening includes assessing patient risk factors or the STOP-BANG tool, which requires an active participant.
We aimed to confirm a connection between FES and OSA in presurgical patients and develop a screening method appropriate
for patients with perioperative OSA risk.
Materials and Methods 162 presurgical pre-anesthesia clinic patients were enrolled. Screening questions determined eligibility. Those who were pregnant or aged < 19 were excluded. Control group included those with a STOP-BANG score < 3.
Experimental group included those with BMI > 35 and OSA diagnosis. Examiners photographed participants’ eyes with
vertical and horizontal retraction while two blinded ophthalmologists used a grading scale to review grade of eyelid laxity.
Results Differences in habitus, ASA score, and hypertension as a comorbidity were significant. Sensitivity of FES screening
was 52% (CI 37–66%) and specificity was 56% (CI 46–66%) for reviewer 1. For reviewer 2, sensitivity was 48% (CI 28–69%)
and specificity was 72% (CI 60–81%). Negative predictive value was 86% (CI 81–90) for reviewer 1 and 88% (CI 83–92%)
for reviewer 2. Inter-rater agreement was moderate.
Conclusion While specificity and sensitivity were lower than anticipated, negative predictive value was high. Given this
strong negative predictive value, our findings indicate using eyelid retraction to screen for FES has perioperative clinical
utility. These findings encourage further research addressing the connection of lid laxity/FES to OSA.
Key Points
• Aimed to investigate if a FES screening tool could identify perioperative OSA risk.
• Negative predictive value for FES with OSA was 86%.
• Observing periocular lid laxity has clinical utility; is feasible in any patient.
Keywords Floppy eyelid syndrome · Eyelid laxity · Obstructive sleep apnea · Screening tool · Perioperative medicine ·
Preoperative assessment
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Obstructive sleep apnea (OSA) challenges anesthesiologists
in perioperative settings. Those with OSA can experience
increased sensitivity to narcotics, airway complications,
cardiac arrest, and anoxic brain injury, with increased risk
for serious perioperative complications [1, 2]. A meta-analysis found the prevalence of OSA in the general population
ranged from 9 to 38%, increasing with age and obesity [3].
OSA may also occur with hypertension, diabetes, and metabolic syndrome [1]. OSA with or without these comorbidities can present as periocular manifestations [1].
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In epidemiological studies, the mean prevalence of OSA
was 22% in men and 17% in women when defined as an
apnea–hypopnea index (AHI) ≥ 5 [4]. In addition, Chan et al.
found that nearly 68% of patients undergoing major noncardiac surgery had unrecognized OSA with increased risk of
30-day postoperative cardiovascular complications based on
preoperative oximetry sleep studies [5]. While exact prevalence is unknown and varies depending on the study, OSA
can present at lower rates in community-screened populations and higher rates in certain subgroups [6]. The literature regarding the effect of OSA on perioperative outcomes
implies that patients with undiagnosed or untreated OSA
may experience an acute perioperative event after receiving
an anesthetic that may exacerbate OSA. Medications used
in the administration of anesthesia relax upper airway structures, leading to obstruction. They also affect lung mechanics, ventilation, oxygenation, and airway protection, all of
which can exacerbate OSA or cause acute airway obstruction
perioperatively. Thus, preoperatively identifying patients
with or at risk for OSA can be of importance.
Floppy eyelid syndrome (FES), a periocular manifestation, was originally described in 1981 [7]. Excessive glycosaminoglycan deposition in the periorbital region results
from prolonged ischemia, inflammation, and reperfusion
injury consistent with OSA. These depositions lead to profound periocular soft tissue laxity, which predispose the eyelids to easy distraction and outward rotation from the ocular
surface, especially during sleep.
Studies [8–12] have shown a positive association between
FES and OSA, but have not addressed association within the
perioperative domain [10] or screening tool development
for FES as a predictor for OSA as a predictor for perioperative complications. Standard perioperative screening
includes assessing risk factors such as snoring, tiredness,
observed apnea, high blood pressure, body mass index
(BMI), age, neck circumference, and male gender. The
STOP-BANG tool [13] is also used, which despite high
sensitivity requires appropriate communication skills, an
awake patient or guardian, and a known health history. It
also requires provider time to measure the patient’s neck and
ask eight screening questions. We aimed to confirm a connection between FES and OSA in presurgical patients and
develop a fast and reliable screening method that can be used
on any patient to identify perioperative OSA.

Methods
Study Participants
Patients referred to the pre-anesthesia surgical clinic
(PASC) prior to surgical intervention between 29 August
2017 and 25 January 2018 were considered for study
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participation. All patients were at least 19 years, which is
the age of consent where the study was conducted. Overall
OSA prevalence in the PASC was based on problem list
data over a 6-month period of 457/2855 patients (16%).
Following Institutional Review Board approval, all study
participants provided written informed consent prior to
intervention. Patients completed screening questions
determining medical history and risk factors for OSA.
A STOP-BANG score was calculated for patients with
no history of OSA. The participants were then divided
into two groups. The OSA group included non-pregnant
adults over 19 years old who were evaluated preoperatively in the PASC with a formal diagnosis of OSA and
a BMI greater than 35. The non-OSA group included
nonpregnant adults over 19 years old who were evaluated
preoperatively in the PASC with no formal diagnosis of
OSA and a STOP-BANG score less than 3. The validated
STOP-BANG questionnaire has high sensitivity in surgical populations with pooled sensitivities to predict any
OSA (84%), moderate-to-severe OSA (91%), and severe
OSA (96%) [14]. Thus, patients with STOP-BANG scores
less than 3 were considered low risk of OSA and used as
controls. Participants diagnosed with FES during the study
were contacted, informed of the potential association with
OSA, and encouraged to discuss with their primary care
physician.

Ophthalmologic Examination
Since ophthalmologists were not readily available in the
PASC to assess lid laxity and diagnose FES, the following
procedure was utilized to assess eyelid laxity: Participants
held a cardboard cover up to the bridge of their nose (to
obscure the face below the eyes), the examiner applied mild
horizontal tension at the lateral canthus, and a photograph
was taken on a digital camera while tension was applied. The
examiner then applied mild vertical tension on the superior
eyelid and another photograph was taken. The same procedure was performed on the contralateral eye. The pictures
were taken from a standardized length of 2 feet from the
subject’s face. The photographs were evaluated independently by two ophthalmologists who were blinded to the
patient histories as well as each other’s interpretations of
the photographs. Eyelid laxity was graded for each photograph based on the diagnostic criteria for FES described by
Chambe et al. [8] in Table 1. Grade 1 represents the clinical definition of lax eyelid syndrome. Grade 2 and higher
represent the clinical definition of FES. Grade 4 was not
assessed by photograph in the present study. Any photograph
with grade 2 or 3 was considered diagnostic of FES in the
patient. Figure 1 shows examples of the types of lid laxity
graded within this study.

Obesity Surgery
Table 1 Diagnostic criteria for floppy eyelid syndrome
Grade 0

Grade 1

Normal laxity Asymptomatic upper eyelid
hyperlaxity
(clinical definition of lax
eyelid syndrome)

Grade 2

Grade 3

Grade 4

Papillary conjunctivitis with
eyelid hyperlaxity
(clinical definition of floppy
eyelid syndrome)

Grade 2 + tarsal eversion when Grade 3 + persisting tarsal
eversion with release of the
the eyelid is horizontally
eyelid
retracted

Chambe et al. [8]
Fig. 1 Examples of the types
of lid laxity graded within the
study: a normal laxity; b mild
laxity; c moderate laxity; d
severe laxity

Statistical Analysis
Descriptive statistics were computed for all variables to
ensure data quality and to evaluate the assumptions of statistical tests. Subgroup comparisons between those with
OSA and those without were also performed on key demographic and medical history variables with the χ2 test, T
test for means, and Wilcoxon test for medians. P values
less than 0.05 were considered significant. When presenting results, an asterisk was used to note where Fisher’s
exact test was utilized. The  2 test was used to compare
the proportion of patients with FES (grade 2 or 3 in any
photograph) between the OSA and non-OSA groups. Sensitivity and specificity, and their respective 95% CIs, were
determined for the FES-screening tool with a diagnostic

cut-off of grade 2 in any patient image [14]. Positive predictive values (PPVs), negative predictive values (NPVs),
and likelihood ratios were also calculated. These parameters were determined separately for each ophthalmologist’s
evaluations to analyze inter-rater reliability. Agreement
between the two evaluators in diagnosing FES based on
the image sets was assessed by the kappa statistic. Deidentified patient data from the PASC clinic was utilized
to determine prevalence of OSA in the population being
studied. With an estimated 30% prevalence of OSA in the
study population, the minimum sample size to achieve
80% power and detect a difference between group proportions of 0.26 was determined to be 163, with at least 49
having an OSA diagnosis.
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Results
In total, 162 patients were included: 50 with a formal diagnosis
of OSA by sleep study (OSA group) and 112 with no history of
OSA and STOP-BANG less than 3 (non-OSA group). Of the
162 participants, 157 image sets were evaluated by ophthalmologists and included in the statistical analysis. Four patient
images were lost due to camera memory card malfunction and
one patient image was of inadequate clarity for evaluation. One
patient in the non-OSA group was excluded from data analysis
due to self-reported history of OSA and continuous positive
airway pressure (CPAP) use.
Participant demographics, comorbidities, risk factors, and
screening responses are shown in Table 2. As expected, weight
was significantly higher in the OSA group with a mean weight
of 123.62 kg (SD 24.98) versus a non-OSA group mean weight
of 78.9 kg (SD 17.74) (p < 0.001). Average American Society of Anesthesiology (ASA) score was significantly higher
in the OSA group (p = 0.03). Of the comorbidities analyzed,
only hypertension was significantly more prevalent in the OSA
group than the non-OSA group (p = 0.001).
The true sample prevalence of OSA in the patients who
underwent ophthalmic examination for reviewer 1 was 32%
(CI 25–40) and for reviewer 2 was 25% (CI 17–35). FES was
diagnosed in 52% of the patients in the OSA group and 44% of
the patients in the non-OSA group using a diagnostic cut-off
of grade 2 or higher lid laxity in either horizontal or vertical
traction in either eye.
Regarding FES picture screening characteristics, the results
between the two investigating ophthalmologists were very similar with a computed agreement of 76%. After adjustment for
chance, Cohen’s kappa was determined to be 53%, indicating
moderate inter-rater agreement (41–60% considered moderate).
Using the FES diagnostic cut-off of grade 2 or higher lid laxity,
sensitivity for the FES-based examination was 52% (CI 37–66)
and 48% (CI 28–69) for reviewer 1 and 2, respectively. Specificity was 56% (CI 46–66) and 72% (CI 60–81) for reviewer 1
and 2, respectively. Likelihood Ratio + was calculated at 1.18
(95% CI = 0.84, 1.67) and Likelihood Ratio − was calculated to
be 0.86 (95% CI = 0.61, 1.20). Lid laxity for FES had a positive
predictive value of 18% (CI 14–24) for reviewer 1 and 24%
(CI 16–36) for reviewer 2. A negative predictive value of 86%
(CI 81–90) was seen for reviewer 1 and 88% (CI 83–92) for
reviewer 2. Reviewer outcomes are summarized in Table 3 and
an inter-rater reliability table is referenced in Table 4.

Discussion
We determined the sensitivity of a FES-based screening
tool for OSA in perioperative patients and hypothesized
that it would have a minimum sensitivity of 70%. After
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analysis, sensitivity was 52% (95% CI: 37–66%) using a
FES diagnostic cut-off of grade 2 or higher [8]. STOPBANG scores were not calculated for patients with OSA
diagnosed by sleep study. Thus, we did not directly compare the sensitivity and specificity of the STOP-BANG and
FES-based screening tools within our sample population.
However, the STOP-BANG questionnaire has been validated in meta-analysis with a pooled sensitivity of 84%
when predicting any severity of OSA (95% CI: 81–87%)
(14). The NPV of the STOP-BANG for OSA [14] was
56% (49–62%). We found an NPV of FES for OSA of
86% (81–90%) and 88% (83–92%) between both reviewers
1 and 2, respectively, indicating that using eyelid retraction to screen for FES has perioperative clinical utility.
PPV was low at 18% (14–24%) and 24% (16–36%), likely
because non-OSA and OSA groups were pre-diagnosed
regarding OSA.
The specificity (56%, 95% CI: 46%, 66%) overlapped
with the 95% CI of the meta-analysis that reported a
STOP-BANG pooled specificity for any-OSA of 43%
(95% CI: 38%, 49%) [14]. The FES-based screening tool
proposed here had significantly lower sensitivity (95% CI
46.65%, 62.72%) and similar specificity when compared
to STOP-BANG literature.
FES prevalence was higher in patients with (52%) than
those without known OSA and a STOP-BANG < 3 (44%).
This is consistent with prevalence found in a meta-analysis
that showed a pooled OR of 4.12 for FES in OSA [11].
The gold standard diagnostic tool for OSA is the overnight polysomnogram. It is of little utility in the setting
of urgent or emergent surgery. The STOP-BANG questionnaire was developed to provide a reliable screening
tool for identifying patients at risk for OSA [13] and used
perioperatively to prepare for possible airway and ventilation complications during procedures. The STOP-BANG
questionnaire is recommended for detecting all OSA levels
over the STOP questionnaire, Berlin Questionnaire, and
Epworth Sleepiness Scale [15]. Despite high sensitivity,
the STOP-BANG relies on reliable patient history and
examination, which may not be available in emergent situations. Furthermore, the questionnaire requires the patient
to relay subjective information about snoring and fatigue
as well as an observer able to identify apnea periods. Similar issues arise with the popular Berlin questionnaire [15].
An objective screening tool which does not rely on
patient history would be of utility in urgent and emergent
settings. In addition, it would prompt more in-depth evaluation for OSA in the general population. Some studies
have analyzed biomarkers as a screening tool for undiagnosed OSA; however, no single biomarker has been found
to have sufficient diagnostic strength [16, 17]. In one study,
hemoglobin A1c (HbA1c) plus C-reactive protein (CRP)
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Table 2 Demographics

Age mean (SD)
Age median (IQR)
Height mean cm (SD)
Height median cm (IQR)
Weight mean kg (SD)
Weight median kg (IQR)
BMI mean (SD)
BMI median (IQR)
Female n (%)
Race n (%)
Caucasian, white
African American
Hispanic/Latino
Asian, Pacific Islander
Native American
Other
STOP-BANG score n (%)
0
1
2
3
4
5
6
7
8
ASA score n (%)
1
2
3
4
5
Comorbidities n (%):
CAD
CHF
DM
COPD
TIA/CVA
Hyperlipidemia
Hypertension
Renal insufficiency
Cancer
Patient history n (%)
Smoking history
Drug abuse
Alcohol use
Obstructive sleep apnea
Home CPAP use
Current home narcotic use
*

OSA negative—control group OSA positive—experimental
(n = 112)
group (n = 50)

p value

57.06 (16.24)
59.00 (46.50, 69.25)
167.47 (9.03)
165.75 (161.30, 172.70)
78.69 (17.74)
76.45 (66.10, 89.70)
27.55 (6.03)
26.00 (23.00, 31.00)
86 (76.8)

56.92 (11.63)
58.50 (48.00, 66.00)
170.97 (10.55)
169.60 (162.60, 177.80)
123.62 (24.98)
120.90 (103.40, 134.42)
41.70 (7.29)
40.00 (36.00, 44.75)
29 (58.0)

0.955
0.707
0.032
0.057
< 0.001
< 0.001
< 0.001
< 0.001
0.025
0.186*

101 (90.2)
10 (8.9)
1 (0.9)
0 (0.0)
0 (0.0)
0 (0.0)

44 (88.0)
3 (6.0)
2 (4.0)
0 (0.0)
1 (2.0)
0 (0.0)

13 (11.6)
39 (34.8)
60 (53.6)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)

0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
1 (33.3)
2 (66.7)

1 (0.9)
21 (18.8)
78 (69.6)
12 (10.7)
0 (0.0)

0 (0.0)
2 (4.0)
44 (88.0)
4 (8.0)
0 (0.0)

9 (8.0)
3 (2.7)
18 (16.1)
14 (12.5)
9 (8.0)
29 (25.9)
53 (47.3)
11 (9.8)
23 (20.5)

9 (18.0)
5 (10.0)
13 (26.0)
5 (10.0)
2 (4.0)
19 (38.0)
39 (78.0)
5 (10.0)
8 (16.0)

0.111
0.111
0.205
0.847
0.545
0.170
0.001
1.000
0.644

60 (53.6)
4 (3.6)
49 (44.1)
1 (0.9)
1 (0.9)
18 (16.4)

25 (50.0)
4 (8.0)
21 (43.8)
50 (100.0)
46 (92.0)
6 (12.0)

0.802
0.426
1.000
< 0.001
< 0.001
0.633

< 0.001*

0.033*

Fisher’s exact test
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Table 3 Reviewer outcomes

Estimated facility prevalence
Detection rate
Apparent test prevalence
True sample prevalence
Accuracy (95% CI)
Sensitivity
Specificity
PPV
NPV

Table 4 Inter-reviewer reliability
Reviewer 2

Reviewer 1

OSA

No

Yes

Missing

Total

No
Yes
Missing
Total

43
23
–
66

1
32
–
33

40
18
5
63

84
73
5
162

Note: Although computed agreement is high (76%) among the n = 99
that had their assessments on same individuals done, indicating better than average inter-rater reliability, after accounting for chance
agreement using Cohen’s kappa, the kappa value is 0.53 and can be
regarded as indicative of inter-rater moderate (kappa values of 0.41–
0.60) agreement for the classification that was used. No = Chambe
et al. [8] score < 2; Yes = Chambe et al. [8] score ≥ 2; Missing = subjects not scored

plus erythropoietin (EPO) was found to be superior to the
Epworth Sleepiness Scale and STOP-BANG questionnaire
in screening for OSA [18]. However, delay for laboratory
testing is not practical in the acute setting.
Another option would be the “OSA Score” developed by
Friedman et al. that included BMI, modified Mallampati grade,
and tonsil size [19]. In one study, the OSA Score, using a score
cut-off of ≥ 6 to predict AHI ≥ 5 (mild or higher OSA), had a
sensitivity of 86.3% and a specificity of 46.8% [6]. Despite
high sensitivity of the OSA score, the Mallampati score cannot be assessed in unconscious or uncooperative patients, thus
rendering this tool ineffective in the trauma setting. This is an
issue because, in the trauma setting, suspicion of OSA may
change therapy. A patient suspected of OSA may be sent to
the ICU postoperatively or require close monitoring, resulting
in increased resource utilization and cost.
Per meta-analysis, incidence of FES in OSA increases
with OSA severity, with increased OR values of 2.56, 4.62,
and 7.64 for mild, moderate, and severe OSA, respectively
[11]. In the present study, participants with diagnosed OSA
were also on CPAP therapy. The extent to which CPAP
therapy affects the clinical course of eyelid laxity remains
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Reviewer 1
Point estimates (95% CIs)

Reviewer 2
Point estimates (95% CIs)

0.16
0.17
0.46 (0.39, 0.55)
0.32 (0.25, 0.40)
0.55 (0.47, 0.63)
0.52 (0.37, 0.66)
0.56 (0.46, 0.66)
0.18 (0.14, 0.24)
0.86 (0.81, 0.90)

0.16
0.12 (0.07, 0.21)
0.33 (0.24, 0.44)
0.25 (0.17, 0.35)
0.66 (0.55, 0.75)
0.48 (0.28, 0.69)
0.72 (0.60, 0.81)
0.24 (0.16, 0.36)
0.88 (0.83,0.92)

uncertain. Kadyan et al. showed no difference in eyelid laxity between CPAP and non-CPAP users despite better tear
film break-up times and less ocular irritation in CPAP users
[20]. McNab reported a case of a patient with complete
reversal of FES after 4 years of treatment for OSA, despite
maintaining a BMI of 39 for the duration of therapy [21].
Acar et al. further showed there was a significant decrease
in FES diagnosed after PAP therapy in 51 patients (74.5%
before PAP and 56.9% after PAP, p < 0.01) [22].
In conclusion, the findings of this study were encouraging
for further research to address the connection of lid laxity
and FES to OSA, and therefore to increased risk of perioperative complications. No singular OSA screening tool exists
for patients unable to participate in such an assessment, and
screening for lid laxity and the degree of FES may serve as
that tool. Some limitations of this study include a small sample size as a pilot study, lack of randomization, and absence
of an anesthesiologist as a scoring judge to evaluate how
well anesthesiologists can identify grades of lid laxity compared to ophthalmologists in a clinical setting. In addition,
participants in the non-OSA group, although at low risk for
OSA, could not be guaranteed to not eventually have a positive diagnosis of OSA. This was not a diagnostic study, and
patients did not have follow-up sleep studies with nocturnal
oximetry or polysomnography to eliminate this bias between
the groups. Further studies are needed, including those with
recruitment of an experimental group of subjects with suspected but undiagnosed OSA, a more standardized approach
for eyelid distraction, longitudinal follow-up to document
any perioperative complications or subsequent diagnosis of
OSA, as well as a cohort of perioperative clinicians in order
to evaluate their skill at identification of lid laxity.
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